Gynae BT 2017
LC 3 y:
90%
morbidity 3y ≥G3: 10% 3% OS 3 y: IGABT/ChTh: 79% NOCECA: 63%
Lindegaard et al. Acta Oncologica 2013
Made with FlippingBook - Online catalogs
LC 3 y:
90%
morbidity 3y ≥G3: 10% 3% OS 3 y: IGABT/ChTh: 79% NOCECA: 63%
Lindegaard et al. Acta Oncologica 2013
Made with FlippingBook - Online catalogs